Harnessing the untapped potential of commensal viruses in genetic medicine
Cell & Gene Therapy Insights 2023; 9(4), 413–416
DOI: 10.18609/cgti.2023.061
Published: 27 April 2023
Viewpoint
Joseph Cabral
“Tissue specificity, immune evasion, re-dosabiity, and lack of integration are all unique attributes that make vectorizing anelloviruses so appealing and compelling...”
